Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.
Miah S, Banks CA, Adams MK, Florens L, Lukong KE, Washburn MP. Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer. Mol Biosyst. 2016 Dec 20; 13(1):42-55.